Agronomics Ltd on Tuesday said its investee and Boston-based plant cell culture company Galy Co entered into a ten-year USD50 million partnership with Suzuran Medical Inc.
The partnership will allow Suzuran to use thousands of tons annually of Galy’s laboratory-grown cotton in its products.
Cellular agriculture and cultivated meat-focused venture capital investor Agronomics said Suzuran will use Galy’s lab-grown cotton, which is grown from cells instead of plants, in products such as cosmetic cotton and cotton sheets, and medical products such as gauze and absorbent cotton for medical and consumer use.
Suzuran has been working with Galy since 2021, Agronomics noted, when they completed a proof-of-concept evaluating the quality of the fibres.
** Click here to read the full-text **
